Læknaneminn - 01.04.2010, Blaðsíða 44

Heimildir
1. Pal D, Mitra AK: MDR- and CYP3A4-mediated drug-
herbal interactions. Life Sciences 2006; 78(18): 2131-2145. 8.
2. Shord SS, Shah K, Lukose A: Drug—Botanical Interactions:
A Review of the Laboratory, Animal, and Human Data for 8
Common Botanicals. Integr Cancer Ther 2009; 8(3): 208-227.
3. Zhou S, Chan E, Pan S-Q, Huang M, Lee EJD:
Pharmacokinetic Interactions of Drugs with St John's
Wort. J Psychopharmacol 2004; 18(2); 262-276.
4. Hellum BH, Hu Z, Nilsen OG: Trade Herbal Products and
Induction of CYP2C19 and CYP2E1 in Cultured Human
Hepatocytes. Basic & Clinical Pharmacology & Toxicology
2009; 105(1); 58-63.
5. Akansha Saxena KPT, Sudeep Roy, Feroz Khan,
Ashok Sharma: Pharmacovigilance: Effects of herbal
components on human drugs interactions involving
Cytochrome P450. Bioinformation 2008; 3(5): 198-204.
6. Liu R LF, Liang R, Wang L, Wang Y: Influence of gingko
extract on metabolism of simvastatin. Zhongguo Zhong
Yao Za Zhi 2009; 34(12); 1578-81.
7. Lau AJ, Chang TKH: Inhibition of Human CYP2B6-
Catalyzed Bupropion Hydroxylation by Ginkgo biloba
Extract: Effect of Terpene Trilactones and Flavonols. Drug
Metab Dispos 2009; 37(9): 1931-1937.
Izzo AA, Ernst E: Interactions Between Herbal Medicines
and Prescribed Drugs: An Updated Systematic Review.
Drugs 2009; 69(13): 1777-179810.2165/11317010-
000000000-00000.
9. Fan L, Tao G-Y, Wang G, et al.: Effects of Ginkgo biloba
Extract Ingestion on the Pharmacokinetics of Talinolol in
Healthy Chinese Volunteers. Ann Pharmacother 2009;
43(5): 944-949.
10. Yu X-Y, Lin S-G, Zhou Z-W, et al.: Role of P-glycoprotein
in Limiting the Brain Penetration of Glabridin, An
Active Isoflavan from the Root of Glycyrrhiza glabra.
Pharmaceutical Research 2007; 24(9): 1668-1690.
11. Chiu J, Yau T, Epstein R: Complications of traditional
Chinese/herbal medicines (TCM)—a guide for perplexed
oncologists and other cancer caregivers. Supportive
Care in Cancer 2009; 17(3): 231-240.
12. Þórhallsdóttir Ó, Ingólfsdóttir K, Jóhannsson M:
Aukaverkanir og milliverkanir náttúrulyfja, náttúruvara
og fæðubótarefna. Læknablaðið 2002; 88(4): 289-97.
13. Helgi Sigurðsson, krabbameinslæknir: Könnun á vegum
göngudeildar krabbameinslækninga LSH. Reykjavík,
2009. Munnleg heimild.
MEÐ. RE.TTU V.ATARÆÐ:i..
Við notum ekkert hvítt hveiti og engan hvítan sykur.
Allar marineringar eru heimalagaðar beint frá hjartanu
og eru án allra aukaefna og MSG.
HÖLLDE EERSKDE FRAVAND.J.
MATDE Á VERÐII. SEM KEMUR
feÉE 711 að: BEQSA